Innovent and IASO Bio Enhance Strategic Collaboration in Cell Therapy

SAN FRANCISCO and SUZHOU, China, July 5, 2024 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks